Month: February 2021

INDIANAPOLIS, Feb. 25, 2021 (GLOBE NEWSWIRE) — Kite Realty Group Trust (NYSE: KRG) has formally announced the next phase in the evolution of Glendale Town Center in Indianapolis, Indiana. Through an innovative, multi-faceted redevelopment that includes new retail, multi-family, outlot, and neighborhood improvement components, KRG will transform the community center to improve the visitor experience and maximize value of the asset.“We are proud of the important role Glendale Town Center has historically played in the city of Indianapolis,” said Tom McGowan, President and COO of Kite Realty Group. “From its beginnings in 1958 as the city’s first traditional enclosed mall, to its conversion into an open-air center in 2007, to the exciting transformation happening today – Glendale shows that great real estate will continue to evolve...

EFECTE OYJ — YHTIÖTIEDOTE — 25.2.2021 KLO 14.15Korjaustiedote: Efecte Oyj:n tilinpäätöstiedote 2020 Efecte Oyj:n 25.2.2021 klo 8:30 julkaiseman tilinpäätöstiedotteen suomenkielinen versio sisälsi terminologisen virheen koskien yhtiön raportoimaa toistuvan liikevaihdon myyntikatetta (recurring gross margin). Tilinpäätöstiedotteen toimitusjohtajan katsauksessa sekä Liikevaihto ja tulos -osiossa käytettiin termiä ”toistuvan liikevaihdon käyttökate”, kun oikea termi on ”toistuvan liikevaihdon myyntikate”. Englanninkielisessä tiedotteessa käytetty termi ”recurring gross margin” on oikea.Efecte Oyj:n 25.2.2021 klo 8:30 julkaiseman suomenkielisen tilinpäätöksen toimintakertomusta on korjattu vastaavasti kyseisen termin osalta. Alla korjatut osiot kokonaisuudessaan:Efecte Oyj:n 25.2021 klo 8:30 julkaisema tilinpäätöstiedote:Toistuvan...

ORLANDO, Fla., Feb. 25, 2021 (GLOBE NEWSWIRE) — Today, we are pleased to introduce a new featured company, and one that is making news in the battle against COVID-19 due to recent achievements for the Company’s technology in the critical diagnostic market.XPhyto Therapeutics Corp. (XPHYF), which is listed in the United States, Canada, and Germany is also involved in CBD, THC and Psychedelics. A discussion of those lucrative markets will be for another missive as we discuss the breaking news about the Company’s rapid tests for COVID-19.Let’s start with the headline:“XPhyto Builds Commercial Team to Launch 25-Minute Covid-19 RT-PCR Test”Here’s what you need to know.The Company has expedited the formation of an experienced commercial team to launch its point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system (“Covid-ID Lab”)...

– SK and Plug Power had a virtual signing ceremony, setting the stage for successful joint projects to come including forming a JV– Through a JV in Asia, the two companies are set to establish a fuel cell factory and accelerate the expansion into Asian markets including ChinaLATHAM, N.Y., Feb. 25, 2021 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leading provider of turnkey hydrogen solutions building the global green hydrogen economy, and SK Group, one of the leading South Korean business groups, announce the completion of the $1.6 billion capital investment to partner in accelerating hydrogen as an alternative energy source in Asian markets. In celebration of kicking off the new partnership, including a plan to form a joint venture company in Asia, the executives of SK and Plug Power had a virtual deal closing...

SCOTTSDALE, Ariz., Feb. 25, 2021 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ:JYNT), a national operator, manager, and franchisor of chiropractic clinics, announced that management plans to present and conduct one-on-one meetings at these conferences in March 2021.DA Davidson 4thAnnual Consumer Growth ConferencePresentation: Thursday, March 11th at 10:15 a.m. PT / 1:15 p.m. ETVirtual 1×1 meetings March 11th33rdAnnual ROTH ConferencePresentation: Wednesday, March 17th at 7:00 a.m. PT / 10:00 a.m. ETVirtual 1×1 meetings March 15th – 17thPresentation materials will be posted on the Investor Relations portion of the company’s website. Interested parties may contact their representatives at the above firms to arrange meetings at the respective events.About The Joint ChiropracticThe Joint Corp. revolutionized access to chiropractic...

Nasal spray may offer room temperature distribution that could reduce logistical challenges for healthcare systems and providersIntranasal administration targets the virus at its point of entry and in a preclinical study induced local nasal mucosal immunity believed to be critical for preventing further viral transmissionGAITHERSBURG, Md., Feb. 25, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has commenced enrollment in a Phase 1 clinical trial of AdCOVID, a single-dose intranasal COVID-19 vaccine candidate. AdCOVID is an adenovirus-vector vaccine designed to stimulate a broad immune response including both systemic immunity (neutralizing antibody) and local immunity (mucosal IgA and resident memory T cells) in the nasal cavity and respiratory tract.The...

Phase 2/3 pivotal Illuminate trial of sepofarsen for LCA10 enrollment complete with top-line data anticipated in H1 2022; Brighten pediatric trial of sepofarsen to begin in 2021; additional data from Phase 1/2 InSight extension study to be reported in H2 2021QR-421a Stellar Phase 1/2 trial for Usher syndrome and non-syndromic retinitis pigmentosa interim analysis on track for late Q1/early Q2 2021Further pipeline progress anticipated with first clinical data in 2021 from QR-1123 program for autosomal dominant retinitis pigmentosa and QR-504a clinical study in Fuchs endothelial corneal dystrophy expected to start in H1 2021Cash runway into 2023LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation...

EEZY OYJ  —  STOCK EXCHANGE RELEASE  —  25 FEBRUARY 2021 AT 14.00Correction to the estimated capital gain from divestment in SwedenEezy announced in December 2020 that it will sell its Swedish subsidiary VMP-Group Sweden AB. The transaction was completed in January 2021.When the final accounting of the divestment was prepared, an error in calculation of the initial estimate of the capital gain was noted. Instead of the earlier estimates of 1.5-1.7 million euro, the capital gain in the consolidated financials will be approx. 0.1 million euro. In addition, approx. 0.2 million euro of related costs will be booked.The original statement that the transaction is not estimated to cause any significant change to Eezy’s balance sheet or future profitability, is still valid.For further information, please contact:Hannu NymanCFOhannu.nyman@eezy.fitel....